1,107
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of anti-nuclear autoantibodies in subjects exposed to natural asbestiform fibers: a cross-sectional study

ORCID Icon, , , , , , , & show all
Pages 24-28 | Received 11 Sep 2017, Accepted 06 Dec 2017, Published online: 14 Dec 2017

References

  • Abakay A, Tanrikulu A, Ayhan M, Imamoglu M, Taylan M, Kaplan M, Abakay O. 2016. High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos. Environ Health Prev Med. 21:82–90.
  • Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel D, Nishimoto N. 2006. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer. 119:1303–1311.
  • American Thoracic Society (ATS). 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 152:S77–S121.
  • Ballan G, Del Brocco A, Loizzo S, Fabbri A, Maroccia Z, Fiorentini C, Travaglione S. 2014. Mode of action of fibrous amphiboles: The case of Biancavilla (Sicily, Italy). Ann Ist Super Sanita. 50:133–138.
  • Bayram M, Dongel I, Bakan N, Yalçin H, Cevit R, Dumortier P, Nemery B. 2013. High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest. 143:164–171.
  • Bernstein D, Dunnigan J, Hesterberg T, Brown R, Velasco J, Barrera R, Hoskins J, Gibbs A. 2013. Health risk of chrysotile revisited. Crit Rev Toxicol. 43:154–183.
  • Biggeri A, Pasetto R, Belli S, Bruno C, Di Maria G, Mastrantonio M, Trinca S, Uccelli R, Comba P. 2004. Mortality from chronic obstructive pulmonary disease and pleural mesothelioma in an area contaminated by natural fiber (fluoro-edenite). Scand J Work Environ Health. 30:249–252.
  • Brown J, Pfau J, Pershouse M, Holian A. 2005. Silica, apoptosis, and autoimmunity. J Immunotoxicol. 1:177–187.
  • Bunderson-Schelvan M, Pfau J, Crouch R, Holian A. 2011. Nonpulmonary outcomes of asbestos exposure. J Toxicol Environ Health B Crit Rev. 14:122–152.
  • Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi M, Dayer J, et al. 2002. Autoantibodies to fibroblasts induce a pro-adhesive and pro-inflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum. 46:1602–1613.
  • Comba P, Gianfagna A, Paoletti L. 2003. Pleural mesothelioma cases in biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 58:229–232.
  • Cooper G, Gilbert K, Greidinger E, James J, Pfau J, Reinlib L, Richardson B, Rose N. 2008. Recent advances and opportunities in research on lupus: Environmental influences and mechanisms of disease. Environ Health Perspect. 116:695–702.
  • Del Papa N, Meroni P, Barcellini W, Sinico A, Radice A, Tincani T, D'Cruz D, Nicoletti F, Borghi M, Khamashita M, et al. 1992. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol. 63:267–274.
  • DeNardo P, Bruni B, Paoletti L, Sirianni B. 2004. Pulmonary fiber burden in sheep living in the Biancavilla area (Sicily): Preliminary results. Sci Total Environ. 325:51–58.
  • Fazzo L, Minelli G, Santis M, Bruno C, Zona A, Marinaccio A, Conti S, Pirastu R, Comba P. 2012. Mesothelioma mortality surveillance and asbestos exposure tracking in Italy. Ann Inst Super Sanita. 48:300–310.
  • Galffy G, Mohammed K, Nasreen N, Ward M, Antony V. 1999. Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model. Oncol Res. 11:187–194.
  • Gangemi S, Rapisarda V, Minciullo P, Di Pasquale G, Lombardo G, Valentino M, Fenga C. 2005. Circulating levels of IL-18 in asbestos-exposed workers. Toxicol Ind Health. 21:125–129.
  • Gianfagna A, Oberti R. 2001. Fluoro-edenite from Biancavilla (Catania, Sicily, Italy): Crystal chemistry of a new amphibole end-member. Am Mineral. 86:1489–1493.
  • Grosse Y, Loomis D, Guyton K, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, et al. 2014. Carcinogenicity of fluoro-edenite, silicon carbide fibers and whiskers, and carbon nanotubes. Lancet Oncol. 15:1427–1428.
  • Gwinn M. 2011. Multiple modes of action of asbestos and related mineral fibers. J Toxicol Environ Health B Crit Rev. 14:1–2.
  • Hess E. 2002. Environmental chemicals and autoimmune disease: Cause and effect. Toxicology. 181:65–70.
  • Lange A, Smolik R, Zatoński W, Szymańska J. 1974. Autoantibodies and serum immunoglobulin levels in asbestos workers. Intl Arch Arbeitsmed. 32:313–325.
  • Ledda C, Cocuzza S, Salerno M, Senia P, Matera S, Rapisarda V, Loreto C. 2017. Occupational exposure to Mount Etna's basaltic dust: Assessment of mutagenic and cytotoxic effects. Mol Med Rep. 15:3350–3354.
  • Ledda C, Costa C, Matera S, Puglisi B, Costanzo V, Bracci M, Fenga C, Rapisarda V, Loreto C. 2017. Immunomodulatory effects in workers exposed to naturally-occurring asbestos fibers. Mol Med Rep. 15:3372–3378.
  • Ledda C, Loreto C, Bracci M, Mangano D, Migliore M, Ricceri V, Musumeci A, Costa C, Pomara C, Rapisarda V. 2016. High risk of pleural plaques and parenchymal abnormalities in women living in Biancavilla (Italy). Future Oncol. 12:63–65.
  • Ledda C, Loreto C, Matera S, Massimino N, Cannizzaro E, Musumeci A, Migliore M, Fenga C, Pomara C, Rapisarda V. 2016. Early effects of fluoro-edenite: Correlation between IL-18 serum levels and pleural and parenchymal abnormalities. Future Oncol. 12:59–62.
  • Ledda C, Loreto C, Pomara C, Rapisarda G, Fiore M, Ferrante M, Bracci M, Santarelli L, Fenga C, Rapisarda V. 2016. Sheep lymph nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ Res. 147:97–101.
  • Ledda C, Pomara C, Bracci M, Mangano D, Ricceri V, Musumeci A, Ferrante M, Musumeci G, Loreto C, Fenga C, et al. 2016. Natural carcinogenic fiber and pleural plaques assessment in a general population: A cross-sectional study. Environ Res. 150:23–29.
  • Ledda C, Rapisarda V. 2016. Malignant pleural mesothelioma: The need to move from research to clinical practice. Arch Med Res. 47:407.
  • Lee R, Strohmeier B, Bunker K, van Orden D. 2008. Naturally occurring asbestos: A recurring public policy challenge. J Hazard Mater. 153:1–21.
  • Loreto C, Carnazza M, Cardile V, Libra M, Lombardo L, Malaponte G, Martinez G, Musumeci G, Papa V, Cocco L. 2009. Mineral fiber-mediated activation of phosphoinositide-specific phospholipase C in human bronchoalveolar carcinoma-derived alveolar epithelial A549 cells. Intl J Oncol. 34:371–376.
  • Loreto C, Rapisarda V, Carnazza M, Musumeci G, Valentino M, Fenga C, Martinez G. 2008. Fluoro-edenite fibres induce lung cell apoptosis: An in vivo study. Histol. Histopathol. 23:319–326.
  • Marchand L, St-Hilaire S, Putnam E, Serve K, Pfau J. 2012. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby, MT. Toxicol Lett. 208:168–173.
  • Martinez G, Loreto C, Rapisarda V, Masumeci G, Valentino M, Carnazza M. 2006. Effects of exposure to fluoro-edenite fiber pollution on the respiratory system: An in vivo model. Histol Histopathol. 21:595–601.
  • Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten C, Gustafsson P, et al. 2005. Standardization of spirometry. Eur Respir J. 26:319–338.
  • Miozzi E, Rapisarda V, Marconi A, Costa C, Polito I, Spandidos D, Libra M, Fenga C. 2016. Fluoro-edenite and carbon nanotubes: The health impact of 'asbestos-like' fibres ). Exp Ther Med. 11:21–27.
  • Musumeci G, Loreto C, Cardile V, Carnazza M, Martinez G. 2010. Immunohistochemical expression of retinoblastoma and phospho-retinoblastoma protein in lung sheep exposed to fluoro-edenite fibers. Anat Sci Intl. 85:74–78.
  • Nigam S, Suthar A, Patel M, Karnik A, Dave S, Kashyap S, Venkaiah K. 1993. Humoral immunological profile of workers exposed to asbestos in asbestos mines. Indian J Med Res. 98:274–277.
  • Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M, Comba P. 2000. Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study. Arch Environ Health. 55:392–398.
  • Peipins L, Lewin M, Campolucci S, Lybarger J, Miller A, Middleton D, Weis C, Spence M, Black B, Kapil V. 2003. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, MT, USA. Environ Health Perspect. 111:1753–1759.
  • Pfau J, Sentissi J, Weller G, Putnam E. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, MT, USA. Environ Health Perspect. 113:25–30.
  • Pfau J, Serve K, Noonan C. 2014. Autoimmunity and asbestos exposure. Autoimmune Dis. 2014:782045
  • Rapisarda V, Caltabiano R, Musumeci G, Castrogiovanni P, Ferrante M, Ledda C, Lombardo C, Graziano A, Cardile V, Loreto C. 2017. Analysis of fibulin-3 after exposure to asbestos-like fibers. Environ Res. 156:381–387.
  • Rapisarda V, Ledda C, Migliore M, Salemi R, Musumeci A, Bracci M, Marconi A, Loreto C, Libra M. 2015. FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study. Future Oncol. 11:35–37.
  • Rapisarda V, Ledda C, Ricceri V, Arena F, Musumeci A, Marconi A, Fago L, Bracci M, Santarelli L, Ferrante M. 2015. Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibers. Oncol Lett. 9:2046–2052.
  • Salazar K, Copeland C, Luebke R. 2012. Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat. J Toxicol Environ Health. 75:351–365.
  • Salazar K, Copeland C, Wood C, Schmid JE, Luebke R. 2013. Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos. J Immunotoxicol. 10:329–333.
  • Sayan M, Mossman B. 2016. The NLRP3 inflammasome in pathogenic particle and fiber-associated lung inflammation and diseases. Part Fiber Toxicol. 2016:13.
  • Soffritti M, Minardi F, Bua L, Degli Esposti D, Belpoggi F. 2004. First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibers present in Etnean volcanic material from Biancavilla (Sicily, Italy). Eur J Oncol. 9:169–175.
  • Sullivan P. 2007. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: Update of a cohort mortality study. Environ Health Perspect. 115:579–585.
  • Tan E, Feltkamp T, Butcher B, Dawkins R, Fritzler M, Gordon T, Hardin J, Kalden J, Lahita R, et al. 1997. Range of anti-nuclear antibodies in 'healthy' individuals. Arthritis Rheum. 40:1601–1611.
  • Turner-Warwick M, Parkes W. 1970. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 3:492–495.
  • Wei B, Jia X, Ye B, Yu J, Zhang B, Zhang X, Lu R, Dong T, Yang L. 2012. Impacts of land use on spatial distribution of mortality rates of cancers caused by naturally-occurring asbestos. J Exposure Sci Environ Epidemiol. 22:516–521.
  • Whitehouse A. 2004. Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: Serial observations in 123 miners, family members, and residents of Libby, Montana. AmJInd Med. 46:219–225.
  • World Health Organization (WHO). 2015. Asbestos: Elimination of asbestos-related diseases. Geneva (Switzerland): WHO.